These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8210064)

  • 1. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study].
    Michalak A; Qureshi IA
    Ann Biol Clin (Paris); 1993; 51(10-11):879-85. PubMed ID: 8210064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carnitine levels in muscle in mice with hyperammonemia: effect of treatment with sodium benzoate].
    Michalak A; Qureshi IA
    Can J Physiol Pharmacol; 1993 Jul; 71(7):439-46. PubMed ID: 8242478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue acylcarnitine and acyl-coenzyme A profiles in chronically hyperammonemic mice treated with sodium benzoate and supplementary L-carnitine.
    Michalak A; Qureshi IA
    Biomed Pharmacother; 1995; 49(7-8):350-7. PubMed ID: 8562862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Pharmacol; 1993 Jan; 45(1):137-46. PubMed ID: 8424807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and inducibility of the hepatic and renal hippurate-synthesizing system in sparse-fur (spf) mutant mice with ornithine transcarbamylase deficiency.
    Qureshi IA; Lebel S; Letarte J
    Biochem Int; 1989 Sep; 19(3):657-66. PubMed ID: 2818615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of transported glycine in the conjugation of sodium benzoate in spf mutant mice with ornithine transcarbamylase deficiency.
    Qureshi I; Rouleau T; Letarte J; Ouellet R
    Biochem Int; 1986 Jun; 12(6):839-46. PubMed ID: 3091026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free and esterified coenzyme A in the liver and muscles of chronically hyperammonemic mice treated with sodium benzoate.
    Michalak A; Qureshi IA
    Biochem Mol Med; 1995 Apr; 54(2):96-104. PubMed ID: 8581365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment.
    Michalak A; Qureshi IA
    Biochem Med Metab Biol; 1990 Apr; 43(2):163-74. PubMed ID: 2346672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine.
    Ratnakumari L; Qureshi IA; Maysinger D; Butterworth RF
    J Pharmacol Exp Ther; 1995 Jul; 274(1):437-43. PubMed ID: 7616428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.
    Batshaw ML; Hyman SL; Coyle JT; Robinson MB; Qureshi IA; Mellits ED; Quaskey S
    Pediatr Res; 1988 Apr; 23(4):368-74. PubMed ID: 3374991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
    Michalak A; Lambert MA; Dallaire L; Melançon SB; Laframboise R; Lemieux B; Qureshi IA
    Diabete Metab; 1990; 16(3):226-33. PubMed ID: 2210018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
    Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
    Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fibrates on the glycine conjugation of benzoic acid in rats.
    Gregus Z; Fekete T; Halászi E; Gyurasics A; Klaassen CD
    Drug Metab Dispos; 1998 Nov; 26(11):1082-8. PubMed ID: 9806950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
    Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
    Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzoic acid metabolism reflects hepatic mitochondrial function in rats with long-term extrahepatic cholestasis.
    Krähenbühl L; Reichen J; Talos C; Krähenbühl S
    Hepatology; 1997 Feb; 25(2):278-83. PubMed ID: 9021934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the glycine cleavage system in hyperammonemia treated with benzoate.
    Kodama H; Fujiwara K; Motokawa Y; Tajiri H; Nose O; Kamoshita S
    Tohoku J Exp Med; 1983 Jul; 140(3):337-8. PubMed ID: 6623463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzoyl-CoA ligase activity in the liver and kidney cortex of weanling guinea pigs treated with various inducers: relationship with hippurate synthesis and carnitine levels.
    Ali A; Qureshi IA
    Dev Pharmacol Ther; 1992; 18(1-2):55-64. PubMed ID: 1483363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability of glycine and coenzyme A limits glycine conjugation in vivo.
    Gregus Z; Fekete T; Varga F; Klaassen CD
    Drug Metab Dispos; 1992; 20(2):234-40. PubMed ID: 1352215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.